Last Close
May 20  •  04:00PM ET
15.47
Dollar change
+0.86
Percentage change
5.85
%
May 20, 8:05 AMPrenetics Global announces a multi-year partnership making author and podcast host Jay Shetty IM8’s global ambassador and a shareholder in the company.
Index
-
P/E
-
EPS (ttm)
-4.11
Insider Own
27.70%
Shs Outstand
15.15M
Perf Week
-11.95%
Market Cap
260.34M
Forward P/E
-
EPS next Y
-0.50
Insider Trans
0.00%
Shs Float
12.17M
Perf Month
-13.96%
Enterprise Value
198.70M
PEG
-
EPS next Q
-0.84
Inst Own
9.77%
Perf Quarter
-19.84%
Income
-58.32M
P/S
2.82
EPS this Y
11.54%
Inst Trans
9.17%
Perf Half Y
31.21%
Sales
92.39M
P/B
1.65
EPS next Y
85.01%
ROA
-25.11%
Perf YTD
-1.78%
Book/sh
9.35
P/C
4.11
EPS next 5Y
-
ROE
-32.24%
52W High
23.63 -34.53%
Perf Year
111.92%
Cash/sh
3.76
P/FCF
-
EPS past 3/5Y
58.51% 34.71%
ROIC
-37.17%
52W Low
5.58 177.24%
Perf 3Y
12.25%
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
91.46% -23.93%
Gross Margin
56.42%
Volatility
11.63% 8.31%
Perf 5Y
-
Dividend TTM
-
EV/Sales
2.15
EPS Y/Y TTM
-11.02%
Oper. Margin
-40.46%
ATR (14)
1.41
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
2.72
Sales Y/Y TTM
201.72%
Profit Margin
-63.13%
RSI (14)
40.88
Dividend Gr. 3/5Y
- -
Current Ratio
2.97
EPS Q/Q
-36.22%
SMA20
-8.21%
Beta
0.14
Payout
-
Debt/Eq
0.01
Sales Q/Q
248.57%
SMA50
-16.48%
Rel Volume
0.97
Prev Close
14.61
Employees
98
LT Debt/Eq
0.00
SMA200
1.45%
Avg Volume
213.45K
Price
15.47
IPO
Jul 16, 2021
Option/Short
Yes / Yes
Trades
Volume
211,708
Change
5.85%
Date Action Analyst Rating Change Price Target Change
Mar-16-26Initiated Lake Street Buy $29
Feb-11-26Initiated Roth Capital Buy $36
Jan-18-23Initiated Cantor Fitzgerald Overweight $7
May-20-26 04:51PM
08:00AM
May-14-26 07:03PM
08:05AM
08:00AM
08:30AM Loading…
May-08-26 08:30AM
May-07-26 08:30AM
Apr-17-26 06:07AM
Apr-14-26 08:00AM
Apr-02-26 09:00AM
Mar-24-26 11:00AM
Mar-18-26 08:30AM
08:00AM
Mar-06-26 08:00AM
Mar-03-26 10:19AM
08:00AM Loading…
08:00AM
Feb-23-26 09:00AM
Feb-19-26 08:30AM
Feb-18-26 11:55AM
09:25AM
09:11AM
Feb-17-26 04:30PM
08:00AM
07:22AM
Feb-13-26 08:00AM
Feb-11-26 09:37AM
08:00AM
Jan-20-26 07:15AM
Jan-07-26 08:26AM
Jan-06-26 08:00AM
09:12AM Loading…
Jan-05-26 09:12AM
08:00AM
Jan-02-26 12:03AM
Jan-01-26 03:30PM
Dec-31-25 12:00PM
Dec-30-25 07:27PM
06:33PM
03:06PM
08:00AM
Dec-23-25 09:08AM
Dec-15-25 12:00PM
Dec-09-25 12:48PM
Nov-25-25 08:49AM
Nov-24-25 07:30AM
Nov-14-25 08:35AM
Nov-10-25 07:24AM
Nov-07-25 07:23AM
Nov-04-25 04:05PM
08:00AM
Oct-31-25 08:31AM
Oct-29-25 04:05PM
Oct-28-25 02:20PM
07:13AM
Oct-27-25 10:12AM
09:52AM
Oct-24-25 08:30PM
Oct-13-25 12:00PM
Oct-08-25 08:04AM
Oct-07-25 08:30AM
Sep-30-25 08:00AM
Sep-25-25 12:00PM
Sep-15-25 07:57AM
Sep-12-25 08:30AM
Sep-08-25 11:02AM
Jun-26-25 04:30AM
Jun-18-25 09:10AM
08:51AM
08:45AM
07:50AM
Jun-13-25 12:15PM
Jun-12-25 08:30AM
Apr-09-25 09:00AM
Mar-18-25 08:30AM
Mar-11-25 08:30AM
Mar-05-25 08:30AM
Feb-11-25 08:30AM
Jan-21-25 08:30AM
Jan-15-25 08:30AM
Dec-19-24 08:30AM
Dec-06-24 08:30AM
Dec-05-24 08:30AM
Dec-04-24 04:05PM
Nov-27-24 08:30AM
Nov-18-24 06:57AM
06:00AM
Nov-12-24 08:30AM
Oct-30-24 04:15PM
Oct-15-24 08:30AM
Oct-07-24 08:30AM
Aug-19-24 08:30AM
Jul-12-24 06:00AM
Jul-11-24 08:30AM
Jul-01-24 08:30AM
Jun-20-24 06:00AM
Jun-18-24 02:52PM
08:30AM
Jun-17-24 08:30AM
Apr-01-24 01:53PM
07:30AM
Feb-09-24 09:25AM
Prenetics Global Ltd. is a health sciences company, which engages in providing consumer health products and services. The firm offers scientifically formulated supplements under the IM8 brand, sports nutrition products under the Europa platform, and direct-to-consumer DNA tests through the CircleDNA brand. It is also involved in establishing a Bitcoin treasury for the exploration of applications within the healthcare ecosystem. The company was founded by Sheng Wu Yeung and Chi Hung Tzang in 2014 and has dual headquartered in Charlotte, the United States and Hong Kong.
Co-FounderMr. Sheng Wu Yeung
Chief Financial OfficerMr. Brian J. Rosin
Chief of Staff to Group CEO & Vice President of People & OperationsMs. Samantha Kwok
Chief Clinical OfficerDr. Senthil Kumar Sundaram M.D.
President of Americas & Executive DirectorMr. David Eric Vanderveen